BioCorRx Inc. (BICX) stock
BICXOTCServices-Specialty Outpatient Facilities, NECFiscal year ends December 31
$0.25+0.00 (0.00%)
Close on Oct 19, 2026Market cap $7.30MP/E –Yield –
BioCorRx net income
Net income is the profit left for shareholders after every expense, interest and tax.
BioCorRx's net income for the twelve months ending Jun 30, 2026 was -$3.16M. For fiscal 2025 it was -$3.44M. The highest annual figure on record is -$13.20K in fiscal 2009.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$3.44M | – |
| FY2024 | Dec 31, 2024 | -$5.11M | – |
| FY2023 | Dec 31, 2023 | -$3.77M | – |
| FY2022 | Dec 31, 2022 | -$4.38M | – |
| FY2021 | Dec 31, 2021 | -$5.21M | – |
| FY2020 | Dec 31, 2020 | -$3.51M | – |
| FY2019 | Dec 31, 2019 | -$6.05M | – |
| FY2018 | Dec 31, 2018 | -$6.58M | – |
| FY2017 | Dec 31, 2017 | -$29.71M | – |
| FY2016 | Dec 31, 2016 | -$5.90M | – |
| FY2015 | Dec 31, 2015 | -$4.67M | – |
| FY2014 | Dec 31, 2014 | -$3.13M | – |
| FY2013 | Dec 31, 2013 | -$3.84M | – |
| FY2012 | Dec 31, 2012 | -$885.81K | – |
| FY2011 | Dec 31, 2011 | -$408.97K | – |
| FY2010 | Dec 31, 2010 | -$154.59K | – |
| FY2009 | Dec 31, 2009 | -$13.20K | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$964.77K | – |
| Q1 FY2026 | Mar 31, 2026 | -$831.23K | – |
| Q4 FY2025 | Dec 31, 2025 | $552.56K | – |
| Q3 FY2025 | Sep 30, 2025 | -$1.92M | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.23M | – |
| Q1 FY2025 | Mar 31, 2025 | -$841.41K | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.16M | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.49M | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.22M | – |
| Q1 FY2024 | Mar 31, 2024 | -$1.24M | – |
| Q4 FY2023 | Dec 31, 2023 | -$969.01K | – |
| Q3 FY2023 | Sep 30, 2023 | -$867.35K | – |
| Q2 FY2023 | Jun 30, 2023 | -$923.55K | – |
| Q1 FY2023 | Mar 31, 2023 | -$1.01M | – |
| Q1 FY2022 | Mar 31, 2022 | -$944.99K | – |
| Q2 FY2021 | Sep 30, 2021 | -$2.43M | – |
| Q1 FY2021 | Mar 31, 2021 | -$1.58M | – |
| Q4 FY2020 | Dec 31, 2020 | -$904.67K | – |
| Q3 FY2020 | Sep 30, 2020 | -$785.17K | – |
| Q2 FY2020 | Jun 30, 2020 | -$738.48K | – |
| Q1 FY2020 | Mar 31, 2020 | -$1.08M | – |
| Q4 FY2019 | Dec 31, 2019 | -$1.20M | – |
| Q3 FY2019 | Sep 30, 2019 | -$1.03M | – |
| Q2 FY2019 | Jun 30, 2019 | -$2.04M | – |
| Q1 FY2019 | Mar 31, 2019 | -$1.77M | – |
| Q4 FY2018 | Dec 31, 2018 | -$2.47M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.89M | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.22M | -110.8% |
| Q1 FY2018 | Mar 31, 2018 | -$1.00M | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.57M | – |
| Q3 FY2017 | Sep 30, 2017 | -$1.10M | – |
| Q2 FY2017 | Jun 30, 2017 | $11.30M | – |
| Q1 FY2017 | Mar 31, 2017 | -$38.34M | – |
| Q4 FY2016 | Dec 31, 2016 | -$1.69M | -31594.8% |
| Q3 FY2016 | Sep 30, 2016 | -$2.61M | – |
| Q2 FY2016 | Jun 30, 2016 | -$1.07M | – |
| Q1 FY2016 | Mar 31, 2016 | -$528.59K | – |
| Q4 FY2015 | Dec 31, 2015 | $5.38K | – |
See a number that looks wrong?